Two-year outcomes of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab

被引：0
|
作者：
Izawa, Hidetomo [1 ]
Azuma, Keiko [1 ]
Matsuda, Aya [2 ]
Shimizu, Kimiko [1 ]
Tan, Xue [1 ]
Inoue, Tatsuya [1 ]
Obata, Ryo [1 ]
机构：
[1] Univ Tokyo Hosp, Bunkyo Ku, Tokyo, Japan
[2] Toranomon Gen Hosp, Tokyo, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
879
引用
收藏
页数：3
相关论文
共 50 条
  • [1] INTRAVITREAL AFLIBERCEPT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION RESISTANT TO INTRAVITREAL RANIBIZUMAB
    Narayan, Daniel
    Muecke, James
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 119 - 119
  • [2] Effects of Intravitreal Aflibercept on Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Ranibizumab
    Suzuki, Katsuya
    Yasukawa, Tsutomu
    Kato, Aki
    Fujino, Shinpei
    Morita, Hiroshi
    Ota, Satoshi
    Hirahara, Shuichiro
    Munenori, Yoshida
    Ogura, Yuichiro
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Two-year Results of "Treat and Extend" Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration
    Akika, Kyo
    Yamamoto, Manabu
    Yasui, Ayako
    Hirayama, Kumiko
    Kohno, Takeya
    Shiraki, Kunihiko
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age-related macular degeneration patients
    Kwon, Y. H.
    Min, J. S.
    Ahn, H.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94
  • [5] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
  • [6] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    [J]. DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [7] Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration A Prospective Study
    Maruko, Ichiro
    Ogasawara, Masashi
    Yamamoto, Akiko
    Itagaki, Kanako
    Hasegawa, Taiji
    Arakawa, Hisaya
    Nakayama, Makiko
    Koizumi, Hideki
    Okada, Annabelle A.
    Sekiryu, Tetsuju
    Iida, Tomohiro
    [J]. OPHTHALMOLOGY RETINA, 2020, 4 (08): : 767 - 776
  • [8] The outcomes of aflibercept therapy in patients with age-related macular degeneration resistant to bevacizumab or ranibizumab
    Unsal, Erkan
    Cubuk, Mehmet Ozgur
    [J]. JOURNAL OF CURRENT OPHTHALMOLOGY, 2018, 30 (04): : 337 - 342
  • [9] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Rachel Hui Fen Lim
    Bhaskar Gupta
    Peter Simcock
    [J]. International Journal of Ophthalmology, 2017, (03) : 423 - 426
  • [10] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Lim, Rachel Hui Fen
    Gupta, Bhaskar
    Simcock, Peter
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (03) : 423 - 426
12345